glp 1 receptor agonists incretin mimetics glp-1_analogs [TUSOM Glucagon-like peptide-1 receptor: mechanisms and

For many years, there has only been one oral GLP-1 available: Rybelsus

& DRI6012 Study Investigatiors

By making minor modifications to what is already disclosed in the original patents, Novo Nordisk has been able to build a thicket of patents that it will use to extract greater profits while attempting to delay competition, which will then in turn be used for share buybacks and the enrichment of shareholders

Ramracheya R, Chapman C, Chibalina M, et al

These factors reinforce the need for individualized treatment plans rather than broad, unsupervised use

1 Introduction Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are two naturally occurring hormonal peptides produced in gastrointestinal tract, knowns as incretins